膜解剖下腹腔镜全胃切除D2根治联合脾胰切除的短期与长期效果
该回顾性研究比较了2013年6月至2018年6月70例胃癌患者行全胃切除联合脾胰切除的疗效,其中腹腔镜组37例、开腹组33例。结果显示腹腔镜组术中出血更少、淋巴结清扫数目更多、术后排气和进食更早、住院时间更短,而并发症发生率和3年总生存率、无病生存率与开腹组无显著差异。
要点
- 腹腔镜组术中出血量为(79.19±39.63)ml,显著少于开腹组的(214.39±152.47)ml(P<0.05)。
- 腹腔镜组淋巴结清扫数目为(47.27±13.94)枚,显著多于开腹组的(35.45±9.81)枚(P<0.05)。
- 两组术后并发症发生率分别为35.13%和27.27%,差异无统计学意义(P>0.05)。
核心结论
- 膜解剖下腹腔镜全胃切除D2根治联合脾胰切除是可行且安全的,可清扫更多胃周淋巴结,具有术中出血少和术后恢复快的优势,不增加术后并发症,长期生存与开腹手术相当。
研究设计与样本
- 回顾性研究,纳入2013年6月至2018年6月70例胃癌行全胃切除联合脾胰切除的患者,腹腔镜组37例,开腹组33例。
主要发现
- 腹腔镜组与开腹组手术时间和阳性淋巴结清扫数目相似。
- 腹腔镜组术中出血量、淋巴结清扫数目、首次排气时间、首次进食时间和术后住院时间均显著优于开腹组(P<0.05)。
- 两组术后并发症发生率分别为35.13%和27.27%,差异无统计学意义(P>0.05);Clavien-Dindo分级并发症无显著差异(P>0.05)。
- K-M生存曲线显示两组3年总生存率和3年无病生存率无显著差异(P>0.05)。
关键数值与推荐
- 术中出血量:腹腔镜组(79.19±39.63)ml vs 开腹组(214.39±152.47)ml(P<0.05)。
- 淋巴结清扫数目:腹腔镜组(47.27±13.94)枚 vs 开腹组(35.45±9.81)枚(P<0.05)。
- 首次排气时间:腹腔镜组(2.92±0.76)d vs 开腹组(3.76±1.09)d(P<0.05)。
- 首次进食时间:腹腔镜组(7.49±0.96)d vs 开腹组(8.27±1.91)d(P<0.05)。
- 术后住院时间:腹腔镜组(11.95±1.90)d vs 开腹组(15.39±4.07)d(P<0.05)。
临床怎么用
- 对于需行全胃切除联合脾胰切除的胃癌患者,在膜解剖指导下可考虑腹腔镜入路,以期减少出血、清扫更多淋巴结并加速术后恢复。
局限性
- 样本量较小(共70例),为回顾性研究,可能影响结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the short- and long-term effect of laparoscopic total gastrectomy in D2 radical treatment combined with spleno-pancreatectomy under membrane anatomy. METHODS: From June 2013 to June 2018, 70 patients with gastric cancer underwent total gastrectomy combined with spleno-pancreatectomy involving 37 cases in laparoscopy group and 33 cases in laparotomy group. The intraoperative and postoperative conditions of patients in the two groups were compared and analyzed. RESULTS: In the laparoscopy group, the operation time and the number of positive lymph node dissection was similar to the laparotomy group. Statistical difference was found in intraoperative bleeding [(79.19 ± 39.63)ml vs (214.39 ± 152.47)m1], the number of lymph node dissection [(47.27 ± 13.94) vs (35.45 ± 9.81)], the first time of aerofluxus [(2.92 ± 0.76)d vs (3.76 ± 1.09)d], the first fluid intake time [(7.49 ± 0.96)d vs (8.27 ± 1.91)d] and the postoperative hospital stay [(11.95 ± 1.90)d vs (15.39 ± 4.07)d] (P < 0.05), So the laparoscopy group was significantly superior to the laparotomy group. The incidences of postoperative complications in laparoscopy group and the laparotomy group were 35.13% and 27.27%, and the difference was not statistically significant. (P > 0.05). No stark difference in postoperative complications of Clavien-Dindo Classification (P > 0.05). The K-M survival curve showed no significant difference in 3-year overall survival (OS) and 3-year disease-free survival (DFS) between the two groups (P > 0.05). CONCLUSION: The laparoscopic total gastrectomy in D2 radical treatment combined with spleno-pancreatectomy under membrane anatomy is feasible and safe, which can remove more perigastric lymph nodes. With advantages of less intraoperative blood loss and fast postoperative recovery, it cannot increase postoperative complications and long-term survival are comparable to open surgery.
引用
- Li Z, Wu H, Lin H, et al. The short- and long-term effect of laparoscopic total gastrectomy in D2 radical treatment combined with spleno-pancreatectomy under membrane anatomy. Surg Endosc. 2022. PMID: 36050612. doi:10.1007/s00464-022-09461-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。